logo

Ocuphire Pharma, Inc. (OCUP)



Trade OCUP now with
  Date
  Headline
6/8/2021 8:12:31 AM Ocuphire Names Jay Pepose To Board
5/18/2021 7:40:10 AM Ocuphire: USPTO Issues Two Patents Covering Late-Stage Drug Candidate Nyxol, Including For The Treatment Of Presbyopia
5/12/2021 7:34:51 AM Ocuphire Pharma Completes Enrollment In VEGA-1 Phase 2 Clinical Trial Of Nyxol With Low-Dose Pilocarpine For Presbyopia